Annual EBIT
-$181.33 M
-$10.13 M-5.92%
31 December 2023
Summary:
AlloVir annual earnings before interest & taxes is currently -$181.33 million, with the most recent change of -$10.13 million (-5.92%) on 31 December 2023. During the last 3 years, it has fallen by -$110.02 million (-154.29%). ALVR annual EBIT is now -4942.58% below its all-time high of -$3.60 million, reached on 31 December 2018.ALVR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.64 M
+$1.63 M+22.38%
30 September 2024
Summary:
AlloVir quarterly earnings before interest & taxes is currently -$5.64 million, with the most recent change of +$1.63 million (+22.38%) on 30 September 2024. Over the past year, it has increased by +$41.32 million (+88.00%). ALVR quarterly EBIT is now -103.28% below its all-time high of -$2.77 million, reached on 31 March 2019.ALVR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$79.57 M
+$41.32 M+34.18%
30 September 2024
Summary:
AlloVir TTM earnings before interest & taxes is currently -$79.57 million, with the most recent change of +$41.32 million (+34.18%) on 30 September 2024. Over the past year, it has increased by +$98.36 million (+55.28%). ALVR TTM EBIT is now -2769.46% below its all-time high of -$2.77 million, reached on 31 March 2019.ALVR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.9% | +88.0% | +55.3% |
| 3 y3 years | -154.3% | +87.6% | +42.9% |
| 5 y5 years | -4942.6% | +33.5% | -362.7% |
ALVR EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -154.3% | at low | at high | +89.9% | at high | +57.9% |
| 5 y | 5 years | -4942.6% | at low | at high | +89.9% | -362.7% | +57.9% |
| alltime | all time | -4942.6% | at low | -103.3% | +89.9% | -2769.5% | +57.9% |
AlloVir EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.64 M(-22.4%) | -$79.57 M(-34.2%) |
| June 2024 | - | -$7.26 M(-68.2%) | -$120.89 M(-24.9%) |
| Mar 2024 | - | -$22.84 M(-47.9%) | -$160.94 M(-11.2%) |
| Dec 2023 | -$181.33 M(+5.9%) | -$43.84 M(-6.7%) | -$181.33 M(+1.9%) |
| Sept 2023 | - | -$46.96 M(-0.7%) | -$177.93 M(+2.3%) |
| June 2023 | - | -$47.30 M(+9.4%) | -$173.92 M(+1.6%) |
| Mar 2023 | - | -$43.23 M(+6.9%) | -$171.24 M(+0.0%) |
| Dec 2022 | -$171.20 M(+0.8%) | -$40.43 M(-5.9%) | -$171.20 M(-8.2%) |
| Sept 2022 | - | -$42.95 M(-3.8%) | -$186.56 M(-1.4%) |
| June 2022 | - | -$44.62 M(+3.3%) | -$189.12 M(+3.8%) |
| Mar 2022 | - | -$43.19 M(-22.6%) | -$182.15 M(+7.3%) |
| Dec 2021 | -$169.82 M | -$55.80 M(+22.6%) | -$169.82 M(+21.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$45.50 M(+20.8%) | -$139.44 M(+18.3%) |
| June 2021 | - | -$37.66 M(+22.0%) | -$117.83 M(+27.6%) |
| Mar 2021 | - | -$30.86 M(+21.4%) | -$92.33 M(+29.5%) |
| Dec 2020 | -$71.31 M(+167.1%) | -$25.42 M(+6.3%) | -$71.31 M(+28.7%) |
| Sept 2020 | - | -$23.90 M(+96.7%) | -$55.40 M(+38.6%) |
| June 2020 | - | -$12.15 M(+23.5%) | -$39.98 M(+18.4%) |
| Mar 2020 | - | -$9.84 M(+3.5%) | -$33.77 M(+26.5%) |
| Dec 2019 | -$26.70 M(+642.5%) | -$9.51 M(+12.1%) | -$26.70 M(+55.3%) |
| Sept 2019 | - | -$8.48 M(+42.6%) | -$17.20 M(+97.2%) |
| June 2019 | - | -$5.95 M(+114.4%) | -$8.72 M(+214.4%) |
| Mar 2019 | - | -$2.77 M | -$2.77 M |
| Dec 2018 | -$3.60 M | - | - |
FAQ
- What is AlloVir annual earnings before interest & taxes?
- What is the all time high annual EBIT for AlloVir?
- What is AlloVir annual EBIT year-on-year change?
- What is AlloVir quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AlloVir?
- What is AlloVir quarterly EBIT year-on-year change?
- What is AlloVir TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AlloVir?
- What is AlloVir TTM EBIT year-on-year change?
What is AlloVir annual earnings before interest & taxes?
The current annual EBIT of ALVR is -$181.33 M
What is the all time high annual EBIT for AlloVir?
AlloVir all-time high annual earnings before interest & taxes is -$3.60 M
What is AlloVir annual EBIT year-on-year change?
Over the past year, ALVR annual earnings before interest & taxes has changed by -$10.13 M (-5.92%)
What is AlloVir quarterly earnings before interest & taxes?
The current quarterly EBIT of ALVR is -$5.64 M
What is the all time high quarterly EBIT for AlloVir?
AlloVir all-time high quarterly earnings before interest & taxes is -$2.77 M
What is AlloVir quarterly EBIT year-on-year change?
Over the past year, ALVR quarterly earnings before interest & taxes has changed by +$41.32 M (+88.00%)
What is AlloVir TTM earnings before interest & taxes?
The current TTM EBIT of ALVR is -$79.57 M
What is the all time high TTM EBIT for AlloVir?
AlloVir all-time high TTM earnings before interest & taxes is -$2.77 M
What is AlloVir TTM EBIT year-on-year change?
Over the past year, ALVR TTM earnings before interest & taxes has changed by +$98.36 M (+55.28%)